TY - JOUR T1 - Effects of psychiatric comorbidity on respiratory drugs and health care utilization JF - European Respiratory Journal JO - Eur Respir J VL - 38 IS - Suppl 55 SP - p1030 AU - Sandra Baldacci AU - Sara Maio AU - Giuseppe Sarno AU - Anna Angino AU - Sonia Cerrai AU - Franca Martini AU - Martina Fresta AU - Francesco Di Pede AU - Giovanni Viegi Y1 - 2011/09/01 UR - http://erj.ersjournals.com/content/38/Suppl_55/p1030.abstract N2 - Background: Psychiatric disorders are significant comorbid conditions in chronic obstructive pulmonary disease (COPD), however their effects on respiratory health care costs are still debated.Aim: To investigate the relationship between psychiatric comorbidity and respiratory health care costs in an epidemiological survey.Methods: 1354 subjects (mean age: 58.0yrs±18.0; 45.3% males) living in Pisa (Central Italy) participated in a cross-sectional study (2009-11) within the IMCA2 (Indicators for Monitoring COPD and Asthma in the EU) project. An interviewer administered questionnaire on socio-demographic characteristics, respiratory symptoms/diseases, cardiovascular diseases (CVD), risk factors and the Hospital Anxiety and Depression Scale were used.Logistic regression analyses, adjusted for smoking habits, age, sex, CVD, were used to evaluate association between respiratory drug, health care utilization and asthma/COPD with (AC+AD) or without anxiety/depression (AC); anxiety/depression without asthma/COPD (AD); neither anxiety/depression nor asthma/COPD (NN).Results: Respiratory medicines use was 27.5% in AC+AD, 22.4% in AC, 1.7% in AD and 2.5% in NN. Respiratory health care use was 50.5% in AC+AD, 36.8% in AC, 11.6% in AD and 5.8% in NN.Respiratory drugs and health care utilization were associated with AC (OR=12.0, 95%CI=6.8-21.1; OR=8.4, 95%CI=5.6-12.6, respectively) and AC+AD (OR=14.5, 95%CI=7.2-29.0; OR=15.6, 95%CI=9.0-26.9, respectively). Health care utilization was also associated with AD (OR=2.1, 95%CI=1.1-3.9).Conclusions: Psychiatric comorbidity in subjects affected by asthma or COPD increases the impact of respiratory disease in terms of respiratory drugs and health care utilization. ER -